Abstracts

Minimal Change in Bone Density and No Association With HIV Factors Over 12 Months in HIV-Infected Men

Background: It has been postulated that HIV infection is associated with increased risk of osteoporosis, mainly seen in clinical trials. There is a paucity of data in real clinical cohorts. We assessed factors associated with reduced bone mineral density (BMD) at baseline and 12 months in HIV-infected men in our clinic cohort. Methodology: Longitudinal study…

Mechanism of Bone Disease in HIV and HCV: Impact*of Tenofovir Exposure and Severity of Liver Disease

Background: Both HIV and HCV infections are associated with an increased risk of osteoporotic fractures. The mechanisms underlying this higher risk are incompletely elucidated. In this analysis, we explore the effects of HIV, HCV and HIV/HCV co-infection on bone health, and assess the relative contributions of TDF exposure and severity of liver disease. Methodology: This…

A Randomized Open Label Study for Comparing Two Doses of Zoledronic Acid in HIV Infected Patients

Background: An increasing proportion of HIV-infected patients need treatment for osteoporosis. The best management of this problem is not well-known. Methodology: This is a randomized, controlled, pilot study to compare the benefit of a biennial use of zoledronic acid with the standard dosage, the annual use, in HIV-infected patients with osteoporosis. A total of 31…

Hand osteoarthritis a joint disorder frequent and more severe in HIV-1 patients: METAFIB-OA Study

Background: Osteoarthritis (OA) is one of the most frequent joint disorders, causing chronic pain and functional disability. Accelerated aging and metabolic syndrome (MetS) are common among HIV-infected patients, both of which are risk factors for OA. We investigated whether HIV-1 patients have OA more frequently than the general population and identified risk factors for hand…

Ontogeny of HIV-Targeted CD4 T Cells During Exclusive and Non-Exclusive Breastfeeding

Background: Mixed breastfeeding (BF) is associated with a higher risk of mother-to-child transmission than exclusive BF (EBF), however the mechanisms of increased risk are unclear. We determined whether feeding practices alter the expression of CD4+ T cell phenotypes with increased susceptibility to HIV. Methodology: We prospectively evaluated 99 HIV-exposed, but uninfected, breastfed Ugandan infants at…

Infant Variants Require More CD4 for Entry than Maternal Variants Regardless of Transmission Route

Background: Despite high level, persistent exposure to virus, the majority of children born to chronically HIV-infected women escape infection. Most infections that do occur are initiated by a single genetic variant selected from a diverse quasi-species swarm. Given the relative paucity of activated, HIV-susceptible CD4+ target cells, particularly in the fetus, we sought to determine…

Maternal HIV Envelope V3-Specific IgG Responses Are a Correlate of Risk of Perinatal Transmission

Background: More than 300,000 infants become vertically-infected with HIV-1 annually, despite the availability of effective antiretroviral prophylaxis regimens. Immunologic interventions, such as a maternal or infant vaccine, will likely be required to eliminate pediatric HIV-1. Immune correlates of risk of HIV-1 acquisition were identified in the moderately-successful RV144 HIV-1 vaccine trial, including the potentially-protective Envelope…

Steady Decline: Temporal Changes in Substance Use by HIV-Positive Pregnant Women in the US

Background: Substance use during pregnancy has implications for HIV transmission, infant outcomes, and maternal outcomes. This study describes changes in and correlates of substance use during pregnancy from 1990-2012 in two US-based cohorts of HIV-infected women. Methodology: All women enrolled in the Women and Infants Transmission Study (WITS) and the Pediatric HIV/AIDS Cohort Study’s Surveillance…

HIV Viral Load and CD4 Cell Count in Untreated Pregnant Women Entering Care in Cape Town South Africa

Background: In many parts of sub-Saharan Africa, CD4+ cell counts are used to determine eligibility for triple-drug antiretroviral therapy (ART) regimens in HIV-infected pregnant women. There is widespread interest in policies for the universal use of ART in pregnancy, regardless of CD4+ count, to reduce viraemia and the subsequent risks of both vertical and horizontal…